SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-003703
Filing Date
2021-03-22
Accepted
2021-03-22 21:33:53
Documents
2
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4024
2 ex24toselli.txt EX-24 4519
  Complete submission text file 0001179110-21-003703.txt   10108
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INVIVO THERAPEUTICS HOLDINGS CORP. 1 KENDALL SQUARE, SUITE B14402 CAMBRIDGE MA 02139
Business Address
Toselli Richard M. (Reporting) CIK: 0001710549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37350 | Film No.: 21762917